News
Clyraguard successfully inactivated the COVID-19 coronavirus (SARS-CoV-2 virus)
Posted on
Clyra Medical Technologies announced that it has received test results showing that its proprietary copper iodine antimicrobial and antiviral product, Clyraguard, successfully inactivated the COVID-19 coronavirus.
BioLargo says interest is 'extreme' in its Clyraguard spray that dispels the coronavirus
Posted on
BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that Clyraguard, a spray developed by its subsidiary Clyra Medical Technologies, was shown to cause complete inactivation of the coronavirus in lab testing. Calvert says Clyraguard is a personal protective spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment from the coronavirus. Original story can be found here.
Clyraguard on NBC
Posted on
Steve Harrison, CEO of ClyraMedical Technologies, speaks to NBC about the deployment of Clyraguard to hospitals and shows how to apply Clyraguard while wearing a face mask.